Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Neurotrophic Keratitis > Is it neurotrophic keratitis or a different ocular condition?
  • Neurotrophic Keratitis

Is it neurotrophic keratitis or a different ocular condition?

Ophthalmology 360

Neurotrophic keratitis (NK) is a rare degenerative corneal disease that can be misdiagnosed as other ocular conditions such as dry eye disease (DED), limbal stem cell deficiency (LSCD), recurrent corneal erosion (RCE), and others.

During a session at the American Society of Cataract and Refractive Surgery Annual Meeting, Sumit Garg, MD, of UCI Health, and Kendall Donaldson, MD, of Bascom Palmer Eye Institute, presented various patient cases and asked the audience to determine whether these were examples of NK or other diseases that may mimic NK.

A key hallmark of NK is “stain without pain.” Corneal sensitivity and staining are important indicators of NK.

The different stages of NK can be characterized as:

  • Stage 1/mild NK: punctate epithelial keratopathy
  • Stage 2/moderate NK: persistent epithelial defect without stromal involvement
  • Stage 3/severe NK: involvement of the stroma that can progress to perforation

Multiple signs of stage 1 NK can overlap with DED, such as corneal punctate staining with fluorescein, narrow tear meniscus, and rapid tear break-up time. Decreased blinking is a key sign of NK that requires patient education and instruction to concentrate on blinking and closing their eyes.

Patients with NK rarely complain of symptoms, as corneal sensation is reduced or absent due to damage to the corneal nerves, thus corneal sensitivity testing can help distinguish DED from NK.

LSCD is characterized by conjunctival epithelial invasion of the cornea, and unlike NK, LSCD symptoms may include pain and/or ocular discomfort. Corneal sensitivity testing may help distinguish LSCD from NK.

RCE symptoms may include eye pain at night or upon awakening, while patients with NK rarely complain of symptoms. RCE is characterized by repeated episodes of eye pain with redness, photophobia, and tearing. Patients may also have a history of corneal trauma.

NK can be progressive, so early identification and treatment is important. It’s also key to educate patients on follow-up to avoid any permanent visual damage and/or surgery. The diagnosis of NK should be based on a detailed review of medical history with clinical exam, followed by corneal sensitivity testing.

Common comorbidities or etiologies of NK include:

  • Ocular: herpes simplex virus, chronic DED, contact lens wear, ocular surgery (eg, LASIK), topical ophthalmic drug toxicity, etc.
  • Central nervous system: stroke, neoplasm, degenerative disorders, etc.
  • Systemic: diabetes, multiple sclerosis, etc.
  • Genetic: Riley-Day syndrome, familial corneal hypoesthesia, etc.

The following conditions may worsen the prognosis of NK:

  • Exposure keratitis
  • Infectious keratitis
  • DED
  • Meibomian gland dysfunction
  • LSCD
  • Diabetes

In conclusion, NK should be suspected when there is a dissociation between clinical signs and reported symptoms—or lack of symptoms in this case.

Share

Related Content

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Neurotrophic Keratitis

Early detection and targeted treatment strategies are critical for optimal outcomes in neurotrophic keratitis

  • Neurotrophic Keratitis

Amniotic membrane improves severe autoimmune-related KCS and NK outcomes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon